{
  "document_id": "DovaPharmaceuticalsInc_20181108_10-Q_EX-10.2_11414857_EX-10.2_Promotion Agreement",
  "file_path": "data/CUAD_v1/full_contract_pdf/Part_I/Promotion/DovaPharmaceuticalsInc_20181108_10-Q_EX-10.2_11414857_EX-10.2_Promotion Agreement.pdf",
  "text_length": 175387,
  "chunk_count": 230,
  "vector_store_path": "output/vector_stores/DovaPharmaceuticalsInc_20181108_10-Q_EX-10.2_11414857_EX-10.2_Promotion Agreement",
  "summary": "setting out (i) the quarterly average number of Sales Representatives during such Calendar Quarter (calculated by taking the sum of\nthe number of Sales Representatives employed by Valeant (or its affiliates) that have incentive compensation packages that comply\nwith the terms of Section 4.1.3 on each Business Day of the Calendar Quarter divided by the number of Business Days in such\nCalendar Quarter) (the \u201c Quarterly Average Sales Force Size \u201d), and (ii) the aggregate actual number of Details for the Product\nmade by its Sales Representatives during such Calendar Quarter, and the number of Details broken down by the name of the\nTarget Professionals,. Through the JSC, the Parties shall agree on a mutually acceptable form of Detail Report.\n(b) Within [***] following the end of each Calendar Quarter during the Term, Valeant shall provide Dova\nwith a written report (each a \u201c Compensation Report \u201d), which describes (i) the details of the incentive compensation package of\n\nentire understanding of the Parties with respect to the subject matter hereof. Any other express or implied agreements and\nunderstandings, negotiations, writings and commitments, either oral or written, in respect to the subject matter hereof (including the\nConfidentiality Agreement, but solely with respect to information which is deemed Confidential Information hereunder) are\nsuperseded by the terms of this Agreement. The Exhibits to this Agreement are incorporated herein by reference and shall be\ndeemed a part of this Agreement. This Agreement may be amended, or any term hereof modified, only by a written instrument duly\nexecuted by authorized representative(s) of both Parties hereto.\n13.9  Headings . The captions to the several Articles, Sections and subsections hereof are not a part of this Agreement, but\nare merely for convenience to assist in locating and reading the several Articles and Sections hereof.\n\ndelivered), Valeant shall deploy its Field Force Personnel that are engaged in Detailing to Detail the Product in accordance with the\nterms of this Agreement. Subject to compliance with the terms of this Agreement, Valeant shall be responsible, in its discretion,\nacting reasonably, for determining the manner in which it allocates and prioritizes the Details, provided that, in so allocating the\nDetails, Valeant shall take into consideration geographic territory, frequency of calls, prescribing levels and other reasonable\nconsiderations. Except as set forth in this Agreement, without the prior written consent of Dova (not to be unreasonably withheld,\ndelayed or conditioned), Valeant shall not conduct any Valeant Activities, other than Detailing, with respect to the Product.\n(b) [***]\n(c) Beginning after [***], Valeant may initiate discussions with Dova, upon at least [***] notice to Dova\n\nthe aggregate, an amount equal to [***] for each Sales Representative for each Calendar Quarter. Any such spiff, spiv or other\nsimilar incentive bonus shall not be included in the calculation of the applicable Sales Representatives incentive compensation\npackage in determining Valeant\u2019s compliance with the terms of Section 4.1.3.\n4.2.2  Records and Reports.\n(a) Valeant shall keep accurate and complete records, consistent with pharmaceutical industry standards,\nof each Detail and its obligations hereunder in connection therewith. Such records shall be kept for the longer of (i) [***] after the\nend of the Calendar Year to which they relate and (ii) such period of time as required by Applicable Laws. Within [***] following\nthe end of each Calendar Quarter during the Term, Valeant shall provide Dova with a written report (each a \u201c Detail Report \u201d),\nsetting out (i) the quarterly average number of Sales Representatives during such Calendar Quarter (calculated by taking the sum of",
  "parties": "are merely for convenience to assist in locating and reading the several Articles and Sections hereof.\n13.10  Independent Contractors . It is expressly agreed that Valeant and Dova shall be independent contractors and that\nthe relationship between the two Parties shall not constitute a partnership, joint venture or agency. Neither Valeant nor Dova shall\nhave the authority to make any statements, representations or commitments of any kind, or to take any action, which shall be\nbinding on the other Party, without the prior written consent of the other Party.\n13.11  Third Party Beneficiaries . Except as set forth in ARTICLE 11, no Person other than Dova or Valeant (and their\nrespective Affiliates and permitted successors and assignees hereunder) shall be deemed an intended beneficiary hereunder or have\nany right to enforce any obligation of this Agreement.\n13.12  Waiver . The waiver by either Party hereto of any right hereunder, or of any failure of the other Party to perform, or\n\nITS AFFILIATES THAT ARISE OUT OF OR RELATE TO THIS AGREEMENT OR IN CONNECTION WITH A\nBREACH OR ALLEGED BREACH OF THIS AGREEMENT, WHETHER IN CONTRACT, TORT, STRICT LIABILITY\nOR OTHERWISE, AND REGARDLESS OF ANY NOTICE OF THE POSSIBILITY OF SUCH DAMAGES. THE\nFOREGOING SENTENCE SHALL NOT LIMIT (1) THE OBLIGATIONS OF EITHER PARTY TO INDEMNIFY THE\nOTHER PARTY FROM AND AGAINST THIRD PARTY CLAIMS UNDER SECTION 11.1 OR 11.2, AS APPLICABLE,\nOR (2) DAMAGES AVAILABLE FOR A PARTY\u2019S BREACH OF THE CONFIDENTIALITY AND NON-USE\nOBLIGATIONS IN ARTICLE 9.\n11.5  Insurance . Each Party acknowledges and agrees that during the Term, it shall maintain, through purchase or self-\ninsurance, adequate insurance, including products liability coverage and comprehensive general liability insurance, adequate to\ncover its obligations under this Agreement and which are consistent with normal business practices of prudent companies similarly\n\nPersonnel, for any compensation, expense reimbursements or benefits (including vacation and holiday remuneration, healthcare\ncoverage or insurance, life insurance, severance or termination of employment benefits, pension or profit-sharing benefits and\ndisability benefits), payroll-related taxes or withholdings, or any governmental charges or benefits (including unemployment and\ndisability insurance contributions or benefits and workmen\u2019s compensation contributions or benefits) that may be imposed upon or\nbe related to the performance by Valeant or such individuals of this Agreement, all of which shall be the sole responsibility of\nValeant, even if it is subsequently determined by any Governmental Authority that any such individual may be an employee or a\ncommon law employee of Dova or any of its Affiliates or is otherwise entitled to such payments and benefits.\n(f) Valeant shall be solely responsible for the acts or omissions of the Field Force Personnel that are not in\n\n1.3 \u201cAffiliate \u201d shall mean, with respect to any Person, any other Person that directly or indirectly controls, is controlled by\nor is under common control with such Person. A Person shall be deemed to control another Person if such Person possesses the\npower to direct or cause the direction of the management, business and policies of such Person, whether through the ownership of\nfifty percent (50%) or more (or such lesser percentage which is the maximum allowed to be owned by a foreign corporation in a\nparticular jurisdiction) of the voting securities of such Person, by contract or otherwise.\n1.4 \u201cAgreement \u201d shall have the meaning set forth in the preamble to this Agreement.\n1.5 \u201cAlliance Managers \u201d shall have the meaning set forth in Section 4.1.4.\n1.6 \u201cAlternate Product \u201d shall mean a pharmaceutical product that is commercialized by Valeant or its Affiliates in the",
  "key_terms": "any right to enforce any obligation of this Agreement.\n13.12  Waiver . The waiver by either Party hereto of any right hereunder, or of any failure of the other Party to perform, or\nof any breach by the other Party, shall not be deemed a waiver of any other right hereunder or of any other breach by or failure of\nsuch other Party whether of a similar nature or otherwise.\n13.13  Cumulative Remedies . No remedy referred to in this Agreement is intended to be exclusive, but each shall be\ncumulative and in addition to any other remedy referred to in this Agreement or otherwise available under law.\n13.14  Waiver of Rule of Construction . Each Party has had the opportunity to consult with counsel in connection with\nthe review, drafting and negotiation of this Agreement. Accordingly, the rule of construction that any ambiguity in this Agreement\nshall be construed against the drafting Party shall not apply.\n\nITS AFFILIATES THAT ARISE OUT OF OR RELATE TO THIS AGREEMENT OR IN CONNECTION WITH A\nBREACH OR ALLEGED BREACH OF THIS AGREEMENT, WHETHER IN CONTRACT, TORT, STRICT LIABILITY\nOR OTHERWISE, AND REGARDLESS OF ANY NOTICE OF THE POSSIBILITY OF SUCH DAMAGES. THE\nFOREGOING SENTENCE SHALL NOT LIMIT (1) THE OBLIGATIONS OF EITHER PARTY TO INDEMNIFY THE\nOTHER PARTY FROM AND AGAINST THIRD PARTY CLAIMS UNDER SECTION 11.1 OR 11.2, AS APPLICABLE,\nOR (2) DAMAGES AVAILABLE FOR A PARTY\u2019S BREACH OF THE CONFIDENTIALITY AND NON-USE\nOBLIGATIONS IN ARTICLE 9.\n11.5  Insurance . Each Party acknowledges and agrees that during the Term, it shall maintain, through purchase or self-\ninsurance, adequate insurance, including products liability coverage and comprehensive general liability insurance, adequate to\ncover its obligations under this Agreement and which are consistent with normal business practices of prudent companies similarly\n\ncover its obligations under this Agreement and which are consistent with normal business practices of prudent companies similarly\nsituated. Each Party shall provide reasonable written proof of the existence of such insurance to the other Party upon request.\nDova does not and will not maintain or procure any worker\u2019s compensation, healthcare, or other insurance for or on behalf of any\nField Force Personnel, all of which shall be Valeant\u2019s sole responsibility. For clarity, the insurance requirements of this Section 11.5\nshall not be construed to create a limit of either Party\u2019s liability with respect to its indemnification obligations under this ARTICLE\n11.\nARTICLE 12  \nTERM AND TERMINATION\n12.1  Term . This Agreement shall become effective as of the Effective Date and, unless earlier terminated as provided in\nthis ARTICLE 12, shall extend until the four (4) year anniversary of the Effective Date (the \u201c Term \u201d).\n\nthe foregoing, (a) either Party may, without the other Party\u2019s consent, assign this Agreement and its rights and obligations hereunder\nin whole or in part to an Affiliate\u037e and (b) Dova may assign this Agreement to a successor in interest in connection with the sale or\nother transfer of all or substantially all of Dova\u2019s assets or rights relating to the Product\u037e provided that such assignee shall remain\nsubject to all of the terms and conditions hereof in all respects and shall assume all obligations of Dova hereunder whether accruing\nbefore or after such assignment. Any permitted assignee shall assume all assigned obligations of its assignor under this Agreement.\nAny attempted assignment not in accordance with this Section 13.2 shall be void. This Agreement shall be binding on, and inure to\nthe benefit of, each Party, and its permitted successors and assigns.\n13.3  Severability . If any one or more of the provisions contained in this Agreement is held invalid, illegal or unenforceable"
}